Getty ImagesNEW DELHI: Shares of Torrent Pharmaceuticals Ltd. traded 0.39 per cent up in Monday's trade at 12:50PM (IST). Around 4,077 shares changed hands on the counter.
The counter opened at Rs 2977.25 and touched an intraday high and low of Rs 3000.0 and Rs 2885.35, respectively, in the session so far. Shares of the company of Torrent Pharmaceuticals Ltd. quoted a 52-week high of Rs 3248.0 and a 52-week low of Rs 2311.3.
As per BSE, the total market cap of the Torrent Pharmaceuticals Ltd. stood at Rs 50232.07 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 2174.0 crore for the quarter ended 30-Jun-2021, up 10.02 per cent from previous quarter's Rs 1976.0 crore and up 5.53 per cent from the year-ago quarter's Rs 2060.0 crore.
The net profit for latest quarter stood at Rs 330.0 crore, up 2.8 per cent from the same quarter a year ago.
As of 30-Sep-2021, DIIs held 6.71 per cent stake in the company, while foreign institutional investors held 11.53 per cent and the promoters 71.25 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 39.84 and a price-to-book ratio of 7.37. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry.
The counter opened at Rs 2977.25 and touched an intraday high and low of Rs 3000.0 and Rs 2885.35, respectively, in the session so far. Shares of the company of Torrent Pharmaceuticals Ltd. quoted a 52-week high of Rs 3248.0 and a 52-week low of Rs 2311.3.
As per BSE, the total market cap of the Torrent Pharmaceuticals Ltd. stood at Rs 50232.07 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 2174.0 crore for the quarter ended 30-Jun-2021, up 10.02 per cent from previous quarter's Rs 1976.0 crore and up 5.53 per cent from the year-ago quarter's Rs 2060.0 crore.
The net profit for latest quarter stood at Rs 330.0 crore, up 2.8 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Sep-2021, DIIs held 6.71 per cent stake in the company, while foreign institutional investors held 11.53 per cent and the promoters 71.25 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 39.84 and a price-to-book ratio of 7.37. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Torrent Pharmaceuticals Ltd. belongs to the Pharma - Indian industry.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
